| pubmed-article:17595771 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17595771 | lifeskim:mentions | umls-concept:C0034802 | lld:lifeskim |
| pubmed-article:17595771 | lifeskim:mentions | umls-concept:C0029925 | lld:lifeskim |
| pubmed-article:17595771 | lifeskim:mentions | umls-concept:C0026882 | lld:lifeskim |
| pubmed-article:17595771 | lifeskim:mentions | umls-concept:C0032207 | lld:lifeskim |
| pubmed-article:17595771 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:17595771 | lifeskim:mentions | umls-concept:C0683598 | lld:lifeskim |
| pubmed-article:17595771 | lifeskim:mentions | umls-concept:C0031928 | lld:lifeskim |
| pubmed-article:17595771 | lifeskim:mentions | umls-concept:C0023981 | lld:lifeskim |
| pubmed-article:17595771 | pubmed:issue | 3B | lld:pubmed |
| pubmed-article:17595771 | pubmed:dateCreated | 2007-6-28 | lld:pubmed |
| pubmed-article:17595771 | pubmed:abstractText | Different studies have demonstrated epidermal growth factor receptor (EGFR) status as an independent prognostic factor for ovarian cancer (OC). Recent studies in non-small cell lung cancer suggest that the presence of a clinical response to tyrosine kinase inhibitors correlates with somatic mutations in the kinase domain of EGFR, exons 18-21. For patients with OC, data are not available on EGFR gene mutation. | lld:pubmed |
| pubmed-article:17595771 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17595771 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17595771 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17595771 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17595771 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17595771 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17595771 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17595771 | pubmed:issn | 0250-7005 | lld:pubmed |
| pubmed-article:17595771 | pubmed:author | pubmed-author:MöbusVV | lld:pubmed |
| pubmed-article:17595771 | pubmed:author | pubmed-author:FabjaniGerhil... | lld:pubmed |
| pubmed-article:17595771 | pubmed:author | pubmed-author:ZeillingerRob... | lld:pubmed |
| pubmed-article:17595771 | pubmed:author | pubmed-author:TongDanD | lld:pubmed |
| pubmed-article:17595771 | pubmed:author | pubmed-author:SehouliJalidJ | lld:pubmed |
| pubmed-article:17595771 | pubmed:author | pubmed-author:MusteaAlexand... | lld:pubmed |
| pubmed-article:17595771 | pubmed:author | pubmed-author:ThomasAnkeA | lld:pubmed |
| pubmed-article:17595771 | pubmed:author | pubmed-author:KoensgenDomin... | lld:pubmed |
| pubmed-article:17595771 | pubmed:author | pubmed-author:BraicuElena... | lld:pubmed |
| pubmed-article:17595771 | pubmed:author | pubmed-author:PirvulescuCri... | lld:pubmed |
| pubmed-article:17595771 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17595771 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:17595771 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17595771 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17595771 | pubmed:pagination | 1527-30 | lld:pubmed |
| pubmed-article:17595771 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:17595771 | pubmed:meshHeading | pubmed-meshheading:17595771... | lld:pubmed |
| pubmed-article:17595771 | pubmed:meshHeading | pubmed-meshheading:17595771... | lld:pubmed |
| pubmed-article:17595771 | pubmed:meshHeading | pubmed-meshheading:17595771... | lld:pubmed |
| pubmed-article:17595771 | pubmed:meshHeading | pubmed-meshheading:17595771... | lld:pubmed |
| pubmed-article:17595771 | pubmed:meshHeading | pubmed-meshheading:17595771... | lld:pubmed |
| pubmed-article:17595771 | pubmed:meshHeading | pubmed-meshheading:17595771... | lld:pubmed |
| pubmed-article:17595771 | pubmed:meshHeading | pubmed-meshheading:17595771... | lld:pubmed |
| pubmed-article:17595771 | pubmed:meshHeading | pubmed-meshheading:17595771... | lld:pubmed |
| pubmed-article:17595771 | pubmed:meshHeading | pubmed-meshheading:17595771... | lld:pubmed |
| pubmed-article:17595771 | pubmed:meshHeading | pubmed-meshheading:17595771... | lld:pubmed |
| pubmed-article:17595771 | pubmed:meshHeading | pubmed-meshheading:17595771... | lld:pubmed |
| pubmed-article:17595771 | pubmed:meshHeading | pubmed-meshheading:17595771... | lld:pubmed |
| pubmed-article:17595771 | pubmed:meshHeading | pubmed-meshheading:17595771... | lld:pubmed |
| pubmed-article:17595771 | pubmed:meshHeading | pubmed-meshheading:17595771... | lld:pubmed |
| pubmed-article:17595771 | pubmed:meshHeading | pubmed-meshheading:17595771... | lld:pubmed |
| pubmed-article:17595771 | pubmed:meshHeading | pubmed-meshheading:17595771... | lld:pubmed |
| pubmed-article:17595771 | pubmed:meshHeading | pubmed-meshheading:17595771... | lld:pubmed |
| pubmed-article:17595771 | pubmed:articleTitle | Epidermal growth factor receptor (EGFR) mutation does not correlate with platinum resistance in ovarian carcinoma. Results of a prospective pilot study. | lld:pubmed |
| pubmed-article:17595771 | pubmed:affiliation | Department of Gynaecology and Obstetrics, Charité, Medical University of Berlin, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany. alexander.mustea@charite.de | lld:pubmed |
| pubmed-article:17595771 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17595771 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17595771 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17595771 | lld:pubmed |
